Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1B/2 Open-Label, Ascending Single and Repeat Dose Clinical Trial Designed to Evaluate the Safety and Efficacy of Light-activated AU-011 for the Treatment of Subjects With Small Primary Choroidal Melanoma

NCT03052127 is registered in ClinicalTrials.gov with Aura Biosciences as lead sponsor.

NCT NCT03052127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03052127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1B/2 Open-Label, Ascending Single and Repeat Dose Clinical Trial Designed to Evaluate the Safety and Efficacy of Light-activated AU-011 for the Treatment of Subjects With Small Primary Choroidal Melanoma
Lead sponsor
Aura Biosciences
Phase
Phase 1/2
Overall status
Completed
Start date
February 27, 2017
Completion date
January 26, 2021
Enrollment
57 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

choroidal melanoma, ocular melanoma, uveal melanoma